CN Patent

CN104055746B — 一种盐酸缬更昔洛韦包衣片剂组合物

Assigned to HEBEI RENHE YIKANG PHARMACEUTICAL CO., LTD. · Expires 2017-06-30 · 9y expired

What this patent protects

本发明提供了一种稳定的盐酸缬更昔洛韦包衣片剂组合物，包括片芯和薄膜衣层，片芯由盐酸缬更昔洛韦和填充剂、崩解剂、粘合剂、稳定剂及润滑剂组成。本发明提供的盐酸缬更昔洛韦包衣片剂组合物具有质量好、稳定性高、制备工艺简单、适合工业化生产等特点。

USPTO Abstract

本发明提供了一种稳定的盐酸缬更昔洛韦包衣片剂组合物，包括片芯和薄膜衣层，片芯由盐酸缬更昔洛韦和填充剂、崩解剂、粘合剂、稳定剂及润滑剂组成。本发明提供的盐酸缬更昔洛韦包衣片剂组合物具有质量好、稳定性高、制备工艺简单、适合工业化生产等特点。

Drugs covered by this patent

valganciclovir-hydrochloride (VALGANCICLOVIR HYDROCHLORIDE)

Patent Metadata

Patent number: CN104055746B
Jurisdiction: CN
Classification: —
Expires: 2017-06-30
Drug substance claim: No
Drug product claim: No
Assignee: HEBEI RENHE YIKANG PHARMACEUTICAL CO., LTD.
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.